Role of functional imaging in head and neck squamous cell carcinoma: fluorodeoxyglucose positron emission tomography and beyond.
Positron emission tomography (PET) has emerged as an integral diagnostic tool in the management of head and neck squamous cell carcinoma (HNSCC). This article reviews the usefulness and ongoing dilemmas of fluorine-18 fluorodeoxyglucose (18-F FDG) PET and FDG PET/CT in HNSCC. In addition, it examines the potential role of novel markers and biologic characterization of disease, which in the future may assist in targeted therapeutic strategies.
Porceddu
Sandro V
SV
Division of Cancer Services, Princess Alexandra Hospital, Ipswich Road, Woolloongabba, Brisbane, Queensland, Australia 4102. sandro_porceddu@health.qld.gov.au
Burmeister
Bryan H
BH
Hicks
Rodney J
RJ
D019788:Fluorodeoxyglucose F18 / Q000008:administration & dosage*; D006258:Head and Neck Neoplasms / Q000000981:diagnostic imaging* / Q000532:radiotherapy; D006801:Humans; D008991:Monitoring, Physiologic / Q000379:methods*; D049268:Positron-Emission Tomography / Q000379:methods*; D011859:Radiography; D019275:Radiopharmaceuticals / Q000008:administration & dosage*
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18